Jenni Ilomäki

5.1k total citations · 1 hit paper
154 papers, 2.6k citations indexed

About

Jenni Ilomäki is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jenni Ilomäki has authored 154 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Geriatrics and Gerontology, 34 papers in Cardiology and Cardiovascular Medicine and 33 papers in Epidemiology. Recurrent topics in Jenni Ilomäki's work include Pharmaceutical Practices and Patient Outcomes (46 papers), Health Systems, Economic Evaluations, Quality of Life (29 papers) and Diabetes Treatment and Management (22 papers). Jenni Ilomäki is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (46 papers), Health Systems, Economic Evaluations, Quality of Life (29 papers) and Diabetes Treatment and Management (22 papers). Jenni Ilomäki collaborates with scholars based in Australia, Finland and United States. Jenni Ilomäki's co-authors include J. Simon Bell, Maarit Jaana Korhonen, Danny Liew, Janet K. Sluggett, Richard Ofori‐Asenso, Samanta Lalic, Ella Zomer, Edwin C.K. Tan, Zanfina Ademi and Sarah N. Hilmer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jenni Ilomäki

144 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global Incidence of Frailty and Prefrailty Among Community-Dwelling Older Adults

2019 372 citations Jenni Ilomäki, Zanfina Ademi et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenni Ilomäki Australia	26	1.1k	600	478	439	404	154	2.6k
Zachary A. Marcum United States	32	1.5k 1.3×	720 1.2×	423 0.9×	258 0.6×	354 0.9×	150	3.8k
Patrik Midlöv Sweden	34	1.4k 1.3×	576 1.0×	839 1.8×	254 0.6×	384 1.0×	150	3.3k
Ilene H. Zuckerman United States	35	683 0.6×	656 1.1×	613 1.3×	361 0.8×	357 0.9×	114	3.6k
Andrew L. Gilbert Australia	32	1.3k 1.1×	708 1.2×	553 1.2×	243 0.6×	380 0.9×	94	3.0k
Bhautesh Jani United Kingdom	31	917 0.8×	696 1.2×	626 1.3×	676 1.5×	316 0.8×	106	3.8k
Steven R. Erickson United States	30	572 0.5×	588 1.0×	576 1.2×	400 0.9×	337 0.8×	133	3.3k
Joseph V. Agostini United States	17	841 0.7×	597 1.0×	649 1.4×	353 0.8×	236 0.6×	28	3.1k
Andrew R. Zullo United States	19	730 0.6×	364 0.6×	354 0.7×	329 0.7×	232 0.6×	176	2.0k
Mauro Tettamanti Italy	40	1.4k 1.3×	723 1.2×	443 0.9×	608 1.4×	331 0.8×	200	5.1k
Allen Huang Canada	31	1.9k 1.7×	740 1.2×	445 0.9×	340 0.8×	340 0.8×	77	3.8k

Countries citing papers authored by Jenni Ilomäki

Since Specialization

Citations

This map shows the geographic impact of Jenni Ilomäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenni Ilomäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenni Ilomäki more than expected).

Fields of papers citing papers by Jenni Ilomäki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenni Ilomäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenni Ilomäki. The network helps show where Jenni Ilomäki may publish in the future.

Co-authorship network of co-authors of Jenni Ilomäki

This figure shows the co-authorship network connecting the top 25 collaborators of Jenni Ilomäki. A scholar is included among the top collaborators of Jenni Ilomäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenni Ilomäki. Jenni Ilomäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xia, Ting, Jenni Ilomäki, Louisa Picco, & Suzanne Nielsen. (2025). A cross-sectional study of prescribing of antiseizure medication for the treatment of pain in Australia. International Journal of Clinical Pharmacy. 47(5). 1520–1525. 1 indexed citations

Ademi, Zanfina, et al.. (2025). Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data. Clinical Pharmacology & Therapeutics. 118(5). 1161–1169.

Ilomäki, Jenni, et al.. (2025). Barriers and enablers to deprescribing for people living with cystic fibrosis: Multidisciplinary perspectives. Respiratory Medicine. 242. 108091–108091.

Maro, Judith C., Shirley Wang, Sengwee Toh, et al.. (2024). Tree-based scan statistics to generate drug repurposing hypotheses: a test case using sodium-glucose cotransporter-2 inhibitors. American Journal of Epidemiology. 194(7). 1999–2011.

Xia, Ting, et al.. (2024). Predictors of persistent opioid use in Australian primary care: a retrospective cohort study, 2018–2022. Pain Medicine. 25(12). 748–757. 2 indexed citations

Morton, Jedidiah I, et al.. (2024). Acute kidney injury, renal impairment and renal failure associated with sodium glucose co‐transporter‐2 inhibitors in at‐risk groups: A systematic review. British Journal of Clinical Pharmacology. 90(7). 1541–1558. 2 indexed citations

Morton, Jedidiah I, et al.. (2024). The association between sodium glucose cotransporter‐2 inhibitors vs dipeptidyl peptidase‐4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population‐based cohort study. Journal of Diabetes. 16(4). e13507–e13507. 2 indexed citations

Leung, Miriam T Y, et al.. (2024). Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture. The Journal of Clinical Endocrinology & Metabolism. 109(11). 2793–2801. 3 indexed citations

Abebe, Tamrat, et al.. (2024). Current and Future Cost Burden of Myocardial Infarction in Australia: Dynamic Model. Heart Lung and Circulation. 33. S125–S125. 1 indexed citations

10.

Leung, Miriam T Y, Justin P. Turner, C. Marquina, et al.. (2024). Gabapentinoids and Risk of Hip Fracture. JAMA Network Open. 7(11). e2444488–e2444488. 8 indexed citations

11.

Lee, Hyesung, Yeon‐Hee Baek, Ju Hwan Kim, et al.. (2023). Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study. Age and Ageing. 52(2). 14 indexed citations

12.

Marquina, Clara, et al.. (2023). Temporal and age-specific trends in incidence and 1-year case-fatality of hospitalized ischaemic stroke in Victoria, Australia. Journal of Stroke and Cerebrovascular Diseases. 32(11). 107331–107331. 1 indexed citations

13.

Abebe, Tamrat Befekadu, Jedidiah I Morton, Jenni Ilomäki, & Zanfina Ademi. (2023). Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038. European Heart Journal - Quality of Care and Clinical Outcomes. 10(5). 421–430. 5 indexed citations

14.

Leung, Miriam T Y, et al.. (2023). Hip fracture incidence and post-fracture mortality in Victoria, Australia: a state-wide cohort study. Archives of Osteoporosis. 18(1). 56–56. 13 indexed citations

15.

Luterbach, Courtney, Hongqiang Qiu, Rajnikant Sharma, et al.. (2022). A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial Agents and Chemotherapy. 66(10). e0059122–e0059122. 12 indexed citations

16.

Chen, Esa Y. H., Jenni Ilomäki, Janet K. Sluggett, et al.. (2022). Medication Regimen Complexity and Risk of Bleeding in People Who Initiate Oral Anticoagulants for Atrial Fibrillation: A Population-Based Study. The Journals of Gerontology Series A. 78(3). 470–478. 2 indexed citations

17.

Lalic, Samanta, J. Simon Bell, Hanna Gyllensten, et al.. (2019). Trajectories of sickness absence and disability pension before and after opioid initiation for noncancer pain: a 10-year population-based study. Pain. 160(5). 1224–1233. 9 indexed citations

18.

Ilomäki, Jenni, et al.. (2019). Medication Regimen Complexity In 8 Australian Residential Aged Care Facilities: Impact Of Age, Length Of Stay, Comorbidity, Frailty, And Dependence In Activities Of Daily Living. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Bell, J. Simon, Claire Keen, Janet K. Sluggett, et al.. (2019). Multiple antihypertensive use and risk of mortality in residents of aged care services: a prospective cohort study. Aging Clinical and Experimental Research. 32(8). 1541–1549. 9 indexed citations

20.

Chen, Esa Y. H., Janet K. Sluggett, Jenni Ilomäki, et al.. (2018). Development and validation of the Medication Regimen Simplification Guide for Residential Aged CarE (MRS GRACE). Clinical Interventions in Aging. Volume 13. 975–986. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact